Acumen Pharmaceuticals (ABOS) Other Non-Current Liabilities (2023 - 2025)

Acumen Pharmaceuticals' Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $39000.0 for Q3 2025.

• In Q3 2025, Other Non-Current Liabilities changed N/A year-over-year to $39000.0; the TTM figure through Sep 2025 stood at $39000.0 (changed N/A YoY), while the FY2024 annual figure was $150000.0, down 47.18% from the prior year.
• Other Non-Current Liabilities came in at $39000.0 for Q3 2025 at Acumen Pharmaceuticals, down from $77000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $284000.0 in Q4 2023 to a low of $39000.0 in Q3 2025.
• A 3-year average of $132800.0 and a median of $114000.0 in 2025 frame the typical range for Other Non-Current Liabilities.
• On a YoY basis, Other Non-Current Liabilities climbed as much as 47.18% in 2024 and fell as far as 47.18% in 2024.
• Acumen Pharmaceuticals' Other Non-Current Liabilities stood at $284000.0 in 2023, then plunged by 47.18% to $150000.0 in 2024, then plunged by 74.0% to $39000.0 in 2025.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $39000.0, $77000.0, and $114000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison